EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Role of PARP Inhibitors: A New Hope for Breast Cancer Therapy

Kamalendu De, Malabendu Jana, Bhabadeb Chowdhury, Gloria M Calaf iD, Debasish Roy

International Journal of Molecular Sciences · 19.03.2025 · 26 (6) · 2773

DOI: 10.3390/ijms26062773 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 19.03.2025. Verfasst von Kamalendu De und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences (Botany), Midnapore City College, Midnapore 721129, West Bengal, India. Hauptthemen laut MEDLINE: Poly(ADP-ribose) Polymerase Inhibitors, Breast Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 160 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fondo Nacional de Desarrollo Científico y Tecnológico (FONDECYT/ANID).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tumors formed by the unchecked growth of breast cells are known as breast cancer. The second most frequent cancer in the world is breast cancer. It is the most common cancer among females. In 2022, 2,296,840 women were diagnosed with breast cancer. The therapy of breast cancer is evolving through the development of Poly (ADP-ribose) polymerase (PARP) inhibitors, which are offering people with specific genetic profiles new hope as research into the disease continues. It focuses on patients with BRCA1 and BRCA2 mutations. This review summarizes the most recent research on the mechanisms of action of PARP inhibitors and their implications for breast cancer therapy. We review how therapeutic applications are developing and highlight recent studies showing the effectiveness of these medicines whether used alone or in combination. Furthermore, the significance of customized therapy is highlighted in enhancing patient outcomes as we address the function of genetic testing in identifying candidates for PARP inhibition. Recommendations for future research areas to maximize the therapeutic potential of PARP inhibitors are also included, along with challenges and limits in their clinical usage. The objective of this review is to improve our comprehension of the complex interaction between breast cancer biology and PARP inhibition. This knowledge will help to guide screening approaches, improve clinical practice, and support preventive initiatives for people at risk.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Poly(ADP-ribose) Polymerase InhibitorsBreast NeoplasmsAntineoplastic AgentsHumansFemaleBRCA1 ProteinBRCA2 ProteinMutation

Stichwörter der Autor:innen

BRCA1BRCA2PARP inhibitorsbreast cancertherapytumors

Substanzen

Poly(ADP-ribose) Polymerase InhibitorsBRCA1 ProteinBRCA2 ProteinAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Biological Sciences (Botany), Midnapore City College, Midnapore 721129, West Bengal, India.
  • Department of Neurological Science, Rush University School of Medicine, Chicago, IL 773, USA.
  • HIV Dynamics and Replication Program, National Institute of Health, Frederick, MD 21702, USA.
  • Instituto de Alta Investigación, Universidad de Tarapacá, Arica 1000000, Chile.
  • Department of Natural Sciences, Hostos College of The City University of New York, Bronx, NY 718, USA.

ORCID-Profile: Gloria M Calaf

Förderung

  • Fondo Nacional de Desarrollo Científico y Tecnológico (FONDECYT/ANID)

Zitieren

APA

De, K., Jana, M., Chowdhury, B., Calaf, G. M., & Roy, D. (2025). Role of PARP Inhibitors: A New Hope for Breast Cancer Therapy. International Journal of Molecular Sciences, 26(6), 2773. https://doi.org/10.3390/ijms26062773

Vancouver

De K, Jana M, Chowdhury B, Calaf GM, Roy D. Role of PARP Inhibitors: A New Hope for Breast Cancer Therapy. International Journal of Molecular Sciences. 2025;26(6):2773. doi:10.3390/ijms26062773

BibTeX
@article{De2025,
  author = {De, Kamalendu and Jana, Malabendu and Chowdhury, Bhabadeb and Calaf, Gloria M and Roy, Debasish},
  title = {Role of PARP Inhibitors: A New Hope for Breast Cancer Therapy},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {6},
  pages = {2773},
  doi = {10.3390/ijms26062773}
}
Kostenlos starten →